When it comes to trials, do we get what we pay for?

Randomized clinical trials supported by government agencies are critical for advancing knowledge about a large number of interventions (e.g., generic therapies, health system strategies, and surgery) that are relevant to clinical practice and public health. There is a need, however, for timely publication of trial results, to allow health care providers to use the information promptly. In this issue of the Journal, Gordon et al.1 report a thought-provoking study of 244 trials funded by the National Heart, Lung, and Blood Institute. Although data collection for these trials was completed between January 1, 2000, and December 31, 2011, the results of . . .